maprotiline has been researched along with Tachycardia, Ventricular in 1 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Repeated torsade de pointes tachycardia resulted in hemodynamic compromise and were terminated by defibrillations." | 5.31 | [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects]. ( Bauriedel, G; Lentini, S; Lüderitz, B; Rao, ML; Schröder, R, 2001) |
| "Repeated torsade de pointes tachycardia resulted in hemodynamic compromise and were terminated by defibrillations." | 1.31 | [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects]. ( Bauriedel, G; Lentini, S; Lüderitz, B; Rao, ML; Schröder, R, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lentini, S | 1 |
| Rao, ML | 1 |
| Schröder, R | 1 |
| Lüderitz, B | 1 |
| Bauriedel, G | 1 |
1 other study available for maprotiline and Tachycardia, Ventricular
| Article | Year |
|---|---|
[QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
Topics: Aged; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Coronary Angiography; Diagno | 2001 |